Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

1st Optimal vs NowPatient

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

6.7

1st Optimal

Best for Patients wanting GLP-1 therapy within a lab-driven functional-medicine program
★★★☆☆3.4
Semaglutide GLP-1Tirzepatide GLP-1Oral tablet optionAt-home lab testing
Visit 1st Optimal
6.8

NowPatient

Best for Brand-name GLP-1 access without a compounded route
★★★☆☆3.4

Starting at $1069/mo

BrandFree Consultation
Visit NowPatient

Side-by-Side Comparison

Feature1st OptimalNowPatient
Overall Score6.7/106.8/10
Starting Price$1069/mo
Editorial Rating3.4 ★ /53.4 ★ /5
Features8 features2 features
States Available00
Compounded
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

1st Optimal

Pros

  • Offers both semaglutide and tirzepatide with injectable and oral formats
  • Functional-medicine approach with at-home labs and blood-work interpretation
  • Unlimited coaching and ongoing support included
  • No long-term contracts
  • Board-certified doctors and nurse practitioners referenced

Cons

  • No public monthly pricing disclosed
  • No published state availability list
  • Compounded vs branded sourcing not clarified on site
  • Pricing only revealed after quiz or consultation

NowPatient

Pros

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Cons

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

Our Verdict

Winner: NowPatientScore: 6.8/10

NowPatient edges out 1st Optimal with a higher overall score of 6.8/10 and is particularly strong for Brand-name GLP-1 access without a compounded route. 1st Optimal remains a solid alternative, especially if you're looking for Patients wanting GLP-1 therapy within a lab-driven functional-medicine program.

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring 1st Optimal and NowPatient head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.